This is a really exciting time for research into overdose in general and naloxone in particular. 15 papers this time.
Walley AY, Xuan Z, Hackman HH,
Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A.
BMJ. 2013 Jan 30;346:f174. doi:
10.1136/bmj.f174.
Comments: A long-awaited paper for which the authors deserve high praise, as they have produced the first real evidence of naloxone effectiveness and arguably the most
important contribution to naloxone literature to-date. Although not randomized,
the interrupted time series analysis is respectable and the results are
impressive.
Coffin PO,
Sullivan SD.
Ann Intern
Med. 2013 Jan 1;158(1):1-9. doi: 10.7326/0003-4819-158-1-201301010-00003.
Comments: I’ve wanted to write this paper for
about a decade, when I thought about cost-effectiveness as three to four
calculations on the back of a napkin, rather than years of work and RAM-straining matrices. There’s a long way to go with overdose
research that will certainly contribute to future iterations of the model. In
the meantime, this is probably a fair, if quite conservative, initial estimate. There is one sensitivity analysis – in which naloxone
results in behavior change such that overdose risk is lower – which I suspect may be closer to the actual truth.
Ann Intern Med. 2013 Jan
1;158(1):I-30. doi: 10.7326/0003-4819-158-1-201301010-00001. No abstract
available.
Comments: An excellent editorial from our
colleagues at NIDA and the FDA.
Bohnert AS,
Eisenberg A, Whiteside L, Price A, McCabe SE, Ilgen MA.
Addict
Behav. 2012 Nov 23;38(3):1776-1781. doi: 10.1016/j.addbeh.2012.11.005. [Epub
ahead of print]
Comments: Survey of prescription opioid use
among treatment program patients. Use for reasons other than pain relief was
associated with overdose as well as use of several other agents that increase
the risk of overdose.
Niesters M,
Overdyk F, Smith T, Aarts L, Dahan A.
Br J
Anaesth. 2012 Dec 17. [Epub ahead of print]
Comments: Very intriguing review of opioid
overdose cases among children, identifying three issues associated with
respiratory depression: renal dysfunction, CYP2D6 polymorphism resulting in
rapid accumulation of morphine as a codeine metabolite, and obstructive sleep
apnea.
Centers for
Disease Control and Prevention (CDC).
MMWR Morb
Mortal Wkly Rep. 2012 Dec 14;61:997-1001.
Comments:
Alhaddad H, Cisternino S,
Saubamea B, Schlatter J, Chiadmi F, Risède P, Smirnova M, Cochois-Guégan V,
Tournier N, Baud FJ, Mégarbane B.
Toxicology. 2013 Jan 29. doi:pii:
S0300-483X(13)00018-8. 10.1016/j.tox.2013.01.013. [Epub ahead of print]
Comments: An effort to identify biologic mechanisms
for gender variability to buprenorphine respiratory depression.
Algren DA, Monteilh CP, Punja M,
Schier JG, Belson M, Hepler BR, Schmidt CJ, Miller CE, Patel M, Paulozzi LJ,
Straetemans M, Rubin C.
J Med Toxicol. 2013 Jan 29. [Epub
ahead of print]
Comments: An analysis from the fentanyl-laced
heroin overdose fatality epidemic that struck the eastern United States from
2005-2007. This epidemic was substantial and deserves mention in any modern
history of overdose in North America as it led to the active engagement of
several federal agencies in addressing overdose.
Cerdá M, Ransome Y, Keyes KM,
Koenen KC, Tracy M, Tardiff KJ, Vlahov D, Galea S.
Drug Alcohol Depend. 2013 Jan 25. doi:pii: S0376-8716(13)00003-3.
10.1016/j.drugalcdep.2012.12.027. [Epub ahead of print]
Comments: Interesting analysis of demographic
characteristics among opioid overdose decedents in New York City as the
epidemic of prescription opioid overdose emerged (largely among Caucasians).
Gjersing L, Jonassen KV, Biong S,
Ravndal E, Waal H, Bramness JG, Clausen T.
Scand J Public Health. 2013 Jan
9. [Epub ahead of print]
Comments: Basic and important epidemiology of
drug-related deaths in Oslo. Mostly opioids, lots of contact with social
services prior to death.
Calcaterra S, Glanz J, Binswanger
IA.
Drug Alcohol Depend. 2013 Jan 4. doi:pii:
S0376-8716(12)00459-0. 10.1016/j.drugalcdep.2012.11.018. [Epub ahead of print]
Comments: Nice analysis of WONDER data on
opioid overdose death, comparing heroin to prescription opioids. As we know,
the current epidemic is opioid analgesics, although there has been a more
recent increase in heroin deaths – likely due to the transition that often
occurs from opioid analgesics to heroin.
Centers for Disease Control and
Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2012
Dec 14;61(49):997-1001.
Comments: Useful analysis of buprenorphine
toxicity events in the setting of increased buprenorphine prescription. The
rate of toxic events has actually decreased (from 0.27 to 0.008 per patient
prescribed buprenorphine).
George M, Kitzmiller JP, Ewald
MB, O'Donell KA, Becter ML, Salhanick S.
J Med Toxicol. 2012
Dec;8(4):432-5. doi: 10.1007/s13181-012-0249-8.
Comments: Case report of a massive methadone
overdose in a neonate. I can’t access so don’t know if it was iatrogenic.
Nwulu U, Nirantharakumar K,
Odesanya R, McDowell SE, Coleman JJ.
Eur J Clin Pharmacol. 2013
Feb;69(2):255-9. doi: 10.1007/s00228-012-1327-1. Epub 2012 Jun 17.
Comments: An intriguing look at electronic
record “triggers” to identify adverse events. Administration of naloxone had a
positive-predictive value of 91% for opioid overmedication. This is a secondary
care setting, not an emergency setting. In an emergency or field setting, such
a trigger may still have a high positive predictive value, but the negative
predictive value is likely inadequate to justify its use for out-of-hospital
overdose detection.
Lankenau SE, Teti M, Silva K, Bloom JJ, Harocopos A,
Treese M.
J Urban Health. 2012 Dec;89(6):1004-16. doi:
10.1007/s11524-012-9691-9.
Comments: Interesting qualitative analysis of
prescription opioid use among young injectors.
No comments:
Post a Comment